1. Home
  2. CX vs ICLR Comparison

CX vs ICLR Comparison

Compare CX & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cemex S.A.B. de C.V. Sponsored ADR

CX

Cemex S.A.B. de C.V. Sponsored ADR

N/A

Current Price

$9.42

Market Cap

16.0B

Sector

Industrials

ML Signal

N/A

Logo ICON plc

ICLR

ICON plc

N/A

Current Price

$161.65

Market Cap

13.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CX
ICLR
Founded
1906
1990
Country
Mexico
Ireland
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Commercial Physical & Biological Resarch
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.0B
13.1B
IPO Year
2000
2001

Fundamental Metrics

Financial Performance
Metric
CX
ICLR
Price
$9.42
$161.65
Analyst Decision
Buy
Buy
Analyst Count
15
18
Target Price
$14.81
★ $185.82
AVG Volume (30 Days)
★ 6.1M
967.5K
Earning Date
10-26-2026
10-21-2026
Dividend Yield
★ 1.13%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.01
N/A
Revenue Next Year
$3.61
$3.69
P/E Ratio
$19.03
★ $12.91
Revenue Growth
N/A
N/A
52 Week Low
$8.93
$66.57
52 Week High
$13.67
$203.91

Technical Indicators

Market Signals
Indicator
CX
ICLR
Relative Strength Index (RSI) 29.67 49.06
Support Level N/A $162.32
Resistance Level $13.30 $180.07
Average True Range (ATR) 0.25 6.07
MACD -0.04 0.05
Stochastic Oscillator 0.85 33.62

Price Performance

Historical Comparison
CX
ICLR

About CX Cemex S.A.B. de C.V. Sponsored ADR

Cemex SAB de CV is a ready-mix concrete company that mainly engaged in activities that are oriented to the construction industry, mainly through the production, marketing, sale, and distribution of cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and also provide related services and reliable construction-related services to customers and communities and maintain business relationships in more than 60 countries throughout the world. The company operates in different parts of the world, with operations in Mexico, the United States, the EMEA region and the SCA&C region.

About ICLR ICON plc

Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.

Share on Social Networks: